Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 736–750 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4185 TIMM8A Gene Dystonia-Deafness Syndrome Genetic Test This genetic test analyzes the TIMM8A gene to detect mutations associated with Mohr‑Tranebjaerg syndrome, a rare X-linked disorder causing dystonia and deafness.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TIMM8A gene", "Coding region sequence of the TIMM8A gene"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9%"}, {"name": "Methodology", "reference_range": "Next-Generation Sequencing (NGS), full gene"}, {"name": "Clinical Reporting", "reference_range": "DHA‑compliant, detailed ACMG classification"}] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected Mohr‑Tranebjaerg syndrome", "Family history of dystonia and deafness", "Genetic counseling for at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 93175-2 ICD-10: G24.1, H90.5 Clinical summary This genetic test analyzes the TIMM8A gene to detect mutations associated with Mohr‑Tranebjaerg syndrome, a rare X-linked disorder causing dystonia and deafness.
TEST-4394 TIMP1 Gene Bicuspid Aortic Valve Genetic Test This test evaluates for pathogenic variants in the TIMP1 gene associated with an increased risk of developing bicuspid aortic valve.	Whole blood (EDTA), FTA card, or extracted genomic DNA	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TIMP1 gene"] Parameters [] Preparation [] Indications ["Family history of bicuspid aortic valve", "Personal history suggestive of BAV", "Proactive cardiovascular risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q23.1, Z13.79 Clinical summary This test evaluates for pathogenic variants in the TIMP1 gene associated with an increased risk of developing bicuspid aortic valve.
TEST-5786 TJP1 Deficiency Test This test evaluates the TJP1 gene for pathogenic variants associated with TJP1 deficiency using Next-Generation Sequencing (NGS). It identifies single-nucleotide variants, small in...	Whole blood (EDTA) or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TJP1 gene sequence", "Pathogenic variants in TJP1"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Continue all regular medications unless advised otherwise by your doctor."] Indications ["Suspected TJP1 deficiency", "Diagnosis of metabolic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 103204-5 ICD-10: E88.89 Clinical summary This test evaluates the TJP1 gene for pathogenic variants associated with TJP1 deficiency using Next-Generation Sequencing (NGS). It identifies single-nucleotide variants, small insertions/deletions, and copy-number alterations.
TEST-4662 TMEM216 Gene Joubert Syndrome Type 2 Genetic Test This genetic test identifies pathogenic variants in the TMEM216 gene, which are associated with Joubert syndrome type 2, a rare neurodevelopmental disorder.	Peripheral whole blood (venous draw)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TMEM216 gene", "Single nucleotide variants (SNVs)", "Insertions and deletions (indels)", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected Joubert syndrome type 2", "Family history of ciliopathies", "Carrier screening", "Prenatal testing"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Q04.3 Clinical summary This genetic test identifies pathogenic variants in the TMEM216 gene, which are associated with Joubert syndrome type 2, a rare neurodevelopmental disorder.
TEST-4705 TMEM38B Gene Osteogenesis Imperfecta Type 14 Genetic Test This test evaluates the TMEM38B gene for mutations associated with Osteogenesis Imperfecta type 14.	Peripheral Whole Blood (DNA-stabilizing tube)	3–4 Weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TMEM38B gene sequence", "Pathogenic variants (point mutations, small insertions/deletions, copy number variants)"] Parameters [] Preparation ["No fasting required", "No medication cessation required", "Inform physician of all supplements and medications"] Indications ["Suspected diagnosis of Osteogenesis Imperfecta type 14", "Genetic counselling for families with bone fragility disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21643-8 ICD-10: Q78.0 Clinical summary This test evaluates the TMEM38B gene for mutations associated with Osteogenesis Imperfecta type 14.
TEST-4122 TMEM67 Gene COACH Syndrome Genetic Test This test evaluates the TMEM67 gene for mutations associated with COACH syndrome.	Whole Blood (EDTA), Extracted DNA, or DNA FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TMEM67 gene sequence", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without physician consultation"] Indications ["Clinical suspicion of Joubert spectrum disorders", "Patients with features of COACH syndrome", "Carrier screening for at-risk family members", "Confirmatory diagnosis when neuroimaging shows 'molar tooth sign'"] Measurement technique Confirm with laboratory Codes LOINC: 21759-9 ICD-10: Q04.3 Clinical summary This test evaluates the TMEM67 gene for mutations associated with COACH syndrome.
TEST-4598 TMEM67 Gene Joubert Syndrome Type 6 Genetic Test This test analyzes the TMEM67 gene for variants associated with Joubert syndrome type 6, a rare neurodevelopmental disorder.	Whole Blood (EDTA) or Saliva	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TMEM67 gene sequence", "Pathogenic variants in TMEM67"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected Joubert syndrome type 6", "Neurodevelopmental delay with characteristic features", "Family history of JBTS6"] Measurement technique Confirm with laboratory Codes LOINC: 21663-5 ICD-10: Q04.3 Clinical summary This test analyzes the TMEM67 gene for variants associated with Joubert syndrome type 6, a rare neurodevelopmental disorder.
TEST-4600 TNFAIP3 Gene (Rheumatoid Arthritis Susceptibility) Next‑Generation Sequencing DNA Test This test evaluates the TNFAIP3 gene for variants associated with increased susceptibility to rheumatoid arthritis and related autoimmune disorders.	Whole Blood (EDTA), Extracted DNA, or FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TNFAIP3 gene variants", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion (less than 2 weeks)"] Indications ["Assessment of genetic predisposition to rheumatoid arthritis", "Prognostic stratification in RA patients", "Guiding therapeutic decisions"] Measurement technique Confirm with laboratory Codes LOINC: 69787-6 ICD-10: M05.9, L40.59, Z15.09 Clinical summary This test evaluates the TNFAIP3 gene for variants associated with increased susceptibility to rheumatoid arthritis and related autoimmune disorders.
TEST-4940 TNFRSF13B Gene Common Variable Immunodeficiency Type 2 Genetic Test This genetic test identifies pathogenic variants in the TNFRSF13B gene associated with Common Variable Immunodeficiency Type 2 (CVID2).	Blood / DNA / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNFRSF13B gene"] Parameters [] Preparation ["No fasting required", "Mandatory genetic counseling session before collection", "Parental/guardian consent required for patients under 18"] Indications ["Suspected Common Variable Immunodeficiency Type 2 (CVID2)", "Family history of CVID2", "Recurrent infections with low immunoglobulin levels"] Measurement technique Confirm with laboratory Codes LOINC: 69568-0 ICD-10: D83.8, L98.8, Z13.0 Clinical summary This genetic test identifies pathogenic variants in the TNFRSF13B gene associated with Common Variable Immunodeficiency Type 2 (CVID2).
TEST-4676 TNFSF11 Gene Osteopetrosis, Autosomal Recessive Type 2 Genetic Test This genetic test identifies pathogenic variants in the TNFSF11 gene associated with autosomal recessive osteopetrosis type 2.	Whole Blood (EDTA), Extracted DNA (TE buffer), Dried Blood Spot (FTA Card)	15–20 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNFSF11 gene", "Coding exons and splice junctions of TNFSF11"] Parameters [] Preparation ["No special preparation or fasting is required."] Indications ["Suspected autosomal recessive osteopetrosis type 2", "Evaluation for hematopoietic stem cell transplantation eligibility"] Measurement technique Confirm with laboratory Codes LOINC: 88515-7 ICD-10: Q78.2 Clinical summary This genetic test identifies pathogenic variants in the TNFSF11 gene associated with autosomal recessive osteopetrosis type 2.
TEST-3111 TP63 Gene (Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate) Genetic Test This genetic test detects pathogenic variants in the TP63 gene associated with Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome.	Whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in TP63 gene", "Coding exons and splice junctions"] Parameters [] Preparation ["A genetic counselling session and a detailed three-generation pedigree chart must be completed before sample collection."] Indications ["Suspected diagnosis of AEC syndrome", "Family history of AEC syndrome", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81320-2 ICD-10: Q87.0 Clinical summary This genetic test detects pathogenic variants in the TP63 gene associated with Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate (AEC) syndrome.
TEST-3270 TPI1 Gene Hemolytic Anemia due to Triosephosphate Isomerase Deficiency Genetic Test This genetic test identifies mutations in the TPI1 gene associated with triosephosphate isomerase deficiency, a cause of hemolytic anemia and neurological issues.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPI1 gene", "SNVs, indels, CNVs"] Parameters [] Preparation ["Genetic counselling is mandatory before sample collection"] Indications ["Definitive diagnosis of triosephosphate isomerase deficiency", "Carrier detection", "Prenatal planning"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: D55.2 Clinical summary This genetic test identifies mutations in the TPI1 gene associated with triosephosphate isomerase deficiency, a cause of hemolytic anemia and neurological issues.
TEST-5847 TPK1 Gene Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5) Genetic Test This genetic test identifies pathogenic variants in the TPK1 gene associated with Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5). It utilizes next-generation sequencing to...	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPK1 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Suspected Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5)", "Family history of THMD5", "Neurological symptoms suggestive of a neurometabolic disorder"] Measurement technique Confirm with laboratory Codes LOINC: 94473-7 ICD-10: E53.8 Clinical summary This genetic test identifies pathogenic variants in the TPK1 gene associated with Thiamine Metabolism Dysfunction Syndrome Type 5 (THMD5). It utilizes next-generation sequencing to analyze the entire coding region of the gene.
TEST-6080 TPP1 Gene (Neuronal Ceroid Lipofuscinosis Type 2) Genetic Test This test analyzes the TPP1 gene for mutations associated with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 disease). It identifies pathogenic variants, deletions, or duplications w...	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TPP1 gene", "Copy Number Variations (CNV) in the TPP1 gene"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab about any recent blood transfusions or stem cell transplants."] Indications ["Suspected diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 disease)", "Carrier screening in individuals with family history", "Family planning for individuals at risk"] Measurement technique Confirm with laboratory Codes LOINC: 97746-5 ICD-10: E75.4 Clinical summary This test analyzes the TPP1 gene for mutations associated with Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 disease). It identifies pathogenic variants, deletions, or duplications within the gene.
TEST-6122 TRPM6 Gene Hypomagnesemia Type 1 Genetic Test This genetic test evaluates the TRPM6 gene for mutations associated with hereditary hypomagnesemia type 1.	Peripheral whole blood (EDTA tube)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPM6 gene"] Parameters [] Preparation [] Indications ["Suspected primary familial hypomagnesemia with secondary hypocalcemia", "Family screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 93257-0 ICD-10: E83.42 Clinical summary This genetic test evaluates the TRPM6 gene for mutations associated with hereditary hypomagnesemia type 1.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.